共 190 条
[11]
Harris G(2013)A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial) Eur J Cancer 49 2654-e313S
[12]
Patel A(2013)Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 e278S-325
[13]
Adachi I(2013)The role of chemotherapy in the management of stage IIIA non-small cell lung cancer Am Soc Clin Oncol Educ Book 2013 320-3551
[14]
Edmonds L(2008)Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer J Clin Oncol 26 3543-519
[15]
Song F(2002)The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer J Thorac Cardiovasc Surg 124 511-892
[16]
Rosell R(2003)Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis Ann Intern Med 139 879-821
[17]
Gómez-Codina J(2009)Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer J Thorac Oncol 4 816-1534
[18]
Camps C(2013)18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy J Nucl Med 54 1528-1348
[19]
Maestre J(2010)Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer? J Nucl Med 51 1344-1086
[20]
Padille J(2017)A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC EJNMMI Res 7 8-544